AD Clinical Trial
Official title:
The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive
Alzheimer's disease (AD) is closely related to diabetes (DM). DM will aggravate the progression of AD, but the specific mechanism has not yet been clarified. Previous study found that a key pathological feature of the pancreas in patients with DM is islet amyloid polypeptide, and there is also islet amyloid polypeptide in the brain. Therefore, DM may cause cytotoxicity through the interaction between pancreatic amyloid and brain Aβ protein and further aggravate AD progress. In this study, starting with DM and AD pathological biomarkers, the amyloid PET target molecular probe 18F-AV45 will be used to monitor the dynamic changes of amyloid protein in the brain and pancreas during the development of AD. The completion of this study will provide a new view for understanding the mechanism of DM on AD cognitive dysfunction and effectively preventing and treating these two diseases.
This is a single-center, prospective, and observational study, which mainly focuses on the interaction between pancreatic amyloid and brain Aβ protein and further aggravates AD progress in China. PET imaging will be used on subjects. Previously collected patient data may also be enrolled in this study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04520308 -
An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
|
Phase 4 | |
| Recruiting |
NCT06155201 -
Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders
|
N/A | |
| Recruiting |
NCT06335836 -
The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
|
||
| Active, not recruiting |
NCT02380573 -
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
|
Phase 2 | |
| Terminated |
NCT01733355 -
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
|
Phase 0 | |
| Completed |
NCT03932916 -
Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01190904 -
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
|
N/A | |
| Enrolling by invitation |
NCT06245031 -
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
|
N/A | |
| Active, not recruiting |
NCT05984784 -
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
|
Phase 1/Phase 2 | |
| Completed |
NCT02273895 -
The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study
|
N/A |